Dianthus Therapeutics Inc...

NASDAQ: DNTH · Real-Time Price · USD
20.71
0.46 (2.27%)
At close: Aug 15, 2025, 3:59 PM
20.74
0.14%
After-hours: Aug 15, 2025, 04:10 PM EDT

Dianthus Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-8.55 -1.23 -0.83 -18.57
PEG Ratio
0.12 -0.11 -0.01 0.22
PS Ratio
116.48 18.97 3.69 164.92
PB Ratio
2.06 0.32 -0.53 1.41
P/FCF Ratio
-9.28 -1.45 -0.81 -24.5
P/OCF Ratio
-9.29 -1.45 -0.81 -24.58
OCF/S Ratio
-12.54 -13.04 -4.53 -6.71
Debt / Equity Ratio
0.00 0.00 -0.02 n/a
Quick Ratio
15.22 18.42 9.87 1.75
Current Ratio
15.22 18.42 9.97 1.75
Asset Turnover
0.02 0.02 0.08 0.16
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.24 -0.26 0.64 -0.08
Return on Assets
-0.23 -0.24 -0.34 -1.39
Return on Invested Capital
-0.29 -0.28 -0.39 -18.22
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 0.98 -0.37
Net Profit Margin
-13.63 -15.41 -4.44 -8.88
Pretax Profit Margin
-13.63 -15.41 -4.44 -8.88
Operating Profit Margin
-16.34 -17.05 -4.63 -50.6
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-16.27 -16.92 -4.61 -46.83